Literature DB >> 3176100

Lack of correlation between lithium pharmacokinetic parameters obtained from plasma and saliva.

R Obach1, J Borja, J Pruñonosa, J M Vallès, J Torrent, I Izquierdo, F Jané.   

Abstract

One tablet containing 755 mg of lithium tryptophanate (10.8 mEq of lithium) was administered to eight healthy volunteers. The main pharmacokinetic parameters for the group of subjects were estimated. Pharmacokinetic parameters (mean +/- SD) from plasma and saliva were respectively: half life (t1/2) 17 +/- 6 vs. 21.8 +/- 14 h; mean residence time 23.7 +/- 7.4 vs. 24.4 +/- 15.3 h; total clearance 30.6 +/- 9.3 vs. 28.6 +/- 6.2 ml/h/kg; and apparent volume of distribution 0.71 +/- 0.20 vs. 0.84 +/- 0.37 L/kg. Although the mean pharmacokinetic parameters in plasma and saliva were similar, there was no significant correlation between the calculated parameters in the individual subject (p greater than 0.05). The usefulness of monitoring salivary levels of lithium is questionable.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3176100     DOI: 10.1097/00007691-198803000-00004

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  7 in total

1.  First-dose pharmacokinetics of lithium carbonate in children and adolescents.

Authors:  Robert L Findling; Cornelia B Landersdorfer; Vivian Kafantaris; Mani Pavuluri; Nora K McNamara; Jon McClellan; Jean A Frazier; Linmarie Sikich; Robert Kowatch; Jacqui Lingler; Jon Faber; Perdita Taylor-Zapata; William J Jusko
Journal:  J Clin Psychopharmacol       Date:  2010-08       Impact factor: 3.153

Review 2.  Therapeutic drug monitoring in saliva. An update.

Authors:  R K Drobitch; C K Svensson
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

3.  Lithium in Paediatric Patients with Bipolar Disorder: Implications for Selection of Dosage Regimens via Population Pharmacokinetics/Pharmacodynamics.

Authors:  Cornelia B Landersdorfer; Robert L Findling; Jean A Frazier; Vivian Kafantaris; Carl M J Kirkpatrick
Journal:  Clin Pharmacokinet       Date:  2017-01       Impact factor: 6.447

Review 4.  Population Pharmacokinetic Analyses of Lithium: A Systematic Review.

Authors:  Janthima Methaneethorn
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-02       Impact factor: 2.441

5.  Saliva testing as a means to monitor therapeutic lithium levels in patients with psychiatric disorders: Identification of clinical and environmental covariates, and their incorporation into a prediction model.

Authors:  Georgia M Parkin; Michael J McCarthy; Soe H Thein; Hillary L Piccerillo; Nisha Warikoo; Douglas A Granger; Elizabeth A Thomas
Journal:  Bipolar Disord       Date:  2021-09-24       Impact factor: 5.345

6.  Reverse iontophoresis as a noninvasive tool for lithium monitoring and pharmacokinetic profiling.

Authors:  Benoît Leboulanger; Marc Fathi; Richard H Guy; M Begoña Delgado-Charro
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

7.  Provider Perspectives on the Current Use of Lithium Medications and Lithium Monitoring Practices for Psychiatric Conditions.

Authors:  Georgia M Parkin; Elizabeth A Thomas
Journal:  Neuropsychiatr Dis Treat       Date:  2022-09-15       Impact factor: 2.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.